David Dantzker - Feb 13, 2025 Form 4 Insider Report for SURMODICS INC (SRDX)

Role
Director
Signature
/s/ John Manders, on behalf of David R. Dantzker
Stock symbol
SRDX
Transactions as of
Feb 13, 2025
Transactions value $
-$11
Form type
4
Date filed
2/18/2025, 05:22 PM
Previous filing
Feb 12, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SRDX Common Stock Options Exercise $144K +5.28K +13.48% $27.30 44.4K Feb 13, 2025 Direct
transaction SRDX Common Stock Tax liability -$144K -4.22K -9.5% $34.16 40.2K Feb 13, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SRDX Stock Option (right to buy) Options Exercise $0 -5.28K -100% $0.00 0 Feb 13, 2025 Common Stock 5.28K $27.30 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The amount beneficially owned includes 15,772 restricted stock units (RSUs) that vest on service-based vesting dates and 15,415 DSUs that are vested upon issuance, each of which will be settled in shares of the issuer's common stock on a 1 for 1 basis when the reporting person's service as a director ends.
F2 Fully vested.